Elliot Frohman
Elliot Frohman
Distinguished Senior Fellow (Sabbatical) Stanford University School of Medicine
Verified email at
Cited by
Cited by
Multiple sclerosis—the plaque and its pathogenesis
EM Frohman, MK Racke, CS Raine
New England Journal of Medicine 354 (9), 942-955, 2006
Disease modifying therapies in multiple sclerosis
DS Goodin, EM Frohman, GP Garmany, J Halper, WH Likosky, FD Lublin
Neurology 58 (2), 169-78, 2002
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis
JB Fisher, DA Jacobs, CE Markowitz, SL Galetta, NJ Volpe, ...
Ophthalmology 113 (2), 324-332, 2006
Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
ME Shy, EM Frohman, YT So, JC Arezzo, DR Cornblath, MJ Giuliani, ...
Neurology 60 (6), 898-904, 2003
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis
E Gordon-Lipkin, B Chodkowski, DS Reich, SA Smith, M Pulicken, ...
Neurology 69 (16), 1603-1609, 2007
Immune surveillance in multiple sclerosis patients treated with natalizumab
O Stüve, CM Marra, KR Jerome, L Cook, PD Cravens, S Cepok, ...
Annals of Neurology: Official Journal of the American Neurological …, 2006
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis
LS Talman, ER Bisker, DJ Sackel, DA Long Jr, KM Galetta, JN Ratchford, ...
Annals of neurology 67 (6), 749-760, 2010
Optical coherence tomography: a window into the mechanisms of multiple sclerosis
EM Frohman, JG Fujimoto, TC Frohman, PA Calabresi, G Cutter, ...
Nature clinical practice Neurology 4 (12), 664-675, 2008
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
A Petzold, LJ Balcer, PA Calabresi, F Costello, TC Frohman, EM Frohman, ...
The Lancet Neurology 16 (10), 797-812, 2017
The Global Adherence Project (GAP): A multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosis
V Devonshire, Y Lapierre, R Macdonell, C Ramo‐Tello, F Patti, ...
European Journal of Neurology 18 (1), 69-77, 2011
Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography
S Saidha, SB Syc, MA Ibrahim, C Eckstein, CV Warner, SK Farrell, ...
Brain 134 (2), 518-533, 2011
Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis
SB Syc, S Saidha, SD Newsome, JN Ratchford, M Levy, ET Ford, ...
Brain 135 (2), 521-533, 2012
The neuro-ophthalmology of multiple sclerosis
EM Frohman, TC Frohman, DS Zee, R McColl, S Galetta
The Lancet Neurology 4 (2), 111-121, 2005
Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four‐year study
S Saidha, O Al‐Louzi, JN Ratchford, P Bhargava, J Oh, SD Newsome, ...
Annals of neurology 78 (5), 801-813, 2015
Optical coherence tomography and disease subtype in multiple sclerosis
M Pulicken, E Gordon-Lipkin, LJ Balcer, E Frohman, G Cutter, ...
Neurology 69 (22), 2085-2092, 2007
Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies
JN Ratchford, ME Quigg, A Conger, T Frohman, E Frohman, LJ Balcer, ...
Neurology 73 (4), 302-308, 2009
Assessment: vestibular testing techniques in adults and children: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
TD Fife, RJ Tusa, JM Furman, DS Zee, E Frohman, RW Baloh, T Hain, ...
Neurology 55 (10), 1431-1441, 2000
Multiple sclerosis and the urologist
SE Litwiller, EM FROHMAN, PE Zimmern
The Journal of urology 161 (3), 743-757, 1999
Factors that influence adherence with disease-modifying therapy in MS
K Treadaway, G Cutter, A Salter, S Lynch, J Simsarian, J Corboy, ...
Journal of neurology 256, 568-576, 2009
Ganglion cell loss in relation to visual disability in multiple sclerosis
SD Walter, H Ishikawa, KM Galetta, RE Sakai, DJ Feller, SB Henderson, ...
Ophthalmology 119 (6), 1250-1257, 2012
The system can't perform the operation now. Try again later.
Articles 1–20